PharmiWeb.com - Global Pharma News & Resources
14-Jan-2019

SAVELLA Drug Profile, 2019 - Patents, Clinical Trials, Drug Prices, Annual Sales Revenues and Raw API Sources - ResearchAndMarkets.com

The "SAVELLA Drug Profile, 2019" report has been added to ResearchAndMarkets.com's offering.

SAVELLA Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs. The report focuses on SAVELLA and covers the following critical aspects of this drug:

  • United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Topics Covered

  • Profile for SAVELLA
  • US Patents
  • Paragraph IV Patent Challenges
  • US District Court Litigation
  • International (ex US) Patents
  • Clinical Trials
  • Drug Prices - Average Pharmacy Cost
  • Drug Prices - Best Wholesale Price
  • Annual Sales Revenues
  • Finished Product Suppliers
  • Bulk API Sources

Companies Featured

  • Allergan Inc.
  • Rebel Distributors Corp
  • Abi Chem
  • Abblis Chemicals
  • Tci (Tokyo Chemical Industry)
  • Chemmol
  • Akos Consulting & Solutions
  • Ak Scientific Inc. (Aksci)
  • Chembase.Cn
  • Aurum Pharmatech Llc
  • Key Organics/Bionet
  • Boerchem
  • Alsachim
  • Atomole Scientific Co. Ltd.
  • Abachemscene
  • Medchemexpress Mce
  • Assembly Blocks Pvt. Ltd.
  • An Pharmatech
  • Labseeker
  • Race Chemical
  • Molepedia
  • Yuhao Chemical
  • Chemshuttle
  • Enovation Chemicals
  • Bide Pharmatech Ltd.
  • Abovchem Llc
  • Biosynth
  • LGC Standards
  • Musechem
  • Combi-Blocks
  • Bld Pharm
  • Biochempartner
  • Hairui Chemical
  • Ambeed
  • and more...

For more information about this report visit https://www.researchandmarkets.com/research/hj9bg6/savella_drug?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190114005427/en/

Editor Details

Last Updated: 14-Jan-2019